Abstract
Regulation of peroxisome proliferator-activated receptor gamma (PPARγ) activity is the result of several events. The first control level is the regulation of the expression of PPARγ. Examples of this regulation, during adipogenesis, is the transactivation of the PPARγ promoter by transcription factors of the classical pathway, such as C/EBPs or ADD1/SREBP1, but also newly identified factors, such as E2Fs. When preadipocytes re-enter the cell cycle, PPARγ expression is induced coincident with an increase in DNA synthesis, suggesting the involvement of the E2F family of cell cycle regulators. E2F1 induces PPARγ transcription during clonal expansion, whereas E2F4 represses PPARγ expression during terminal adipocyte differentiation. Hence, E2Fs represent the link between proliferative signaling pathways, triggering clonal expansion, and terminal adipocyte differentiation through regulation of PPARγ expression. A second regulatory level of PPARγ action is interaction with cofactors. We will focus our attention on the atypical PPARγ modulators. We have described an interaction between PPARγ and the retinoblastoma protein, RB, which is both dependent upon ligand binding by PPARγ and upon the phosphorylation status of RB. The interaction between PPARγ and RB decreases the transcriptional activity of PPARγ through recruitment of the histone deacetylase HDAC3. Inhibition of HDAC activity consequently results in a strong activation of PPARγ.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Fajas L, Fruchart JC, Auwerx J . Transcriptional control of adipogenesis. Curr Opin Cell Biol 1998; 10: 165–173.
Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K, Satoh S, Nakano R, Ishii C, Sugiyama T, Eto K, Tsubamoto Y, Okuno A, Murakami K, Sekihara H, Hasegawa G, Naito M, Toyoshima Y, Tanaka S, Shiota K, Kitamura T, Fujita T, Ezaki O, Aizawa S, Nagai R, Tobe K, Kimura S, Kadowaki T . PPARg mediates high-fat diet-induced adipocyte hypertrophy, insulin resistance. Mol Cell 1999; 4: 597–609.
Miles PD, Barak Y, He W, Evans RM, Olefsky JM . Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency. J Clin Invest 2000; 105: 287–292.
Debril MB, Renaud JP, Fajas L, Auwerx J . The pleiotropic functions of peroxisome proliferator-activated receptor gamma. J Mol Med 2001; 79: 30–47.
Ristow M, Muller-Wieland D, Pfeiffer A, Krone W, Kahn CR . Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. New Engl J Med 1998; 339: 953–959.
Deeb S, Fajas L, Nemoto M, Laakso M, Fujimoto W, Auwerx J . A Pro 12 Ala substitution in the human peroxisome proliferator-activated receptor gamma2 is associated with decreased receptor activity, improved insulin sensitivity, lowered body mass index. Nat Genet 1998; 20: 284–287.
Tong Q, Dalgin G, Xu H, Ting CN, Leiden JM, Hotamisligil GS . Function of GATA transcription factors in preadipocyte–adipocyte transition (in process citation). Science 2000; 290: 134–138.
Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL, MacDougald OA . Inhibition of adipogenesis by Wnt signaling. Science 2000; 289: 950–953.
Clarke SL, Robinson CE, Gimble JM . CAAT/enhancer binding proteins directly modulate transcription from the peroxisome proliferator activated receptor γ2 promoter. Biochem Biophys Res Commun 1997; 240: 99–103.
Fajas L, Schoonjans K, Gelman L, Kim JB, Najib J, Martin G, Fruchart JC, Briggs M, Spiegelman BM, Auwerx J . Regulation of PPARγ expression by ADD-1/SREBP-1: implications for adipocyte differentiation, metabolism. Mol Cell Biol 1999; 19: 5495–5503.
Richon V, Lyle RE, McGehee REJ . Regulation, expression of retinoblastoma proteins p107 and p130 during 3T3-L1 adipocyte differentiation. J Biol Chem 1997; 272: 10117–10124.
Fajas L, Landsberg RL, Huss-Garcia Y, Sardet C, Lees JA, Auwerx J . E2Fs regulate adipogenesis. Dev Cell 2002; 3: 39–49.
Nevins JR . E2F: a link between the Rb tumor suppressor protein, viral oncoproteins. Science 1992; 258: 424–429.
Helin K . Regulation of cell proliferation by the E2F transcription factors. Curr Opin Genet Dev 1998; 8: 28–35.
Sardet C, Le Cam L, Fabbrizio E, Vidal M . E2Fs, the retinoblastoma protein family. Progr Gene Expr 1997; 2: 1–62.
Morrison RF, Farmer SR . Role of PPARgamma in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c) and p21(Waf1/Cip1), during adipogenesis. J Biol Chem 1999; 274: 17088–17097.
Glass CK, Rose DW, Rosenfeld MG . Nuclear receptor coactivators. Curr Opin Cell Biol 1997; 9: 222–232.
Auwerx J . PPARγ, the ultimate thrifty gene. Diabetologia 1999; 42: 1033–1049.
Fajas L, Egler V, Reiter R, Hansen J, Kristiansen K, Miard S, Auwerx J . The retinoblastoma-histone deacetylase 3 complex inhibits the peroxisome proliferator-activated receptor gamma and adipocyte differentiation. Dev Cell 2002; 3: 903–910.
Higgins C, Chatterjee S, Cherington V . The block of adipocyte differentiation by a C-terminally truncated, but not by full-length, simian virus 40 large tumor antigen is dependent on an intact retinoblastoma susceptibility protein family binding domain. J Virol 1996; 70: 745–752.
Chen PL, Riley DJ, Chen Y, Lee WH . Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes Dev 1996; 10: 2794–2804.
Acknowledgements
Dr J Auwerx and the various members of the Fajas lab are acknowledged for support and discussion. The research in the laboratory of the author was supported by grants of INSERM (Avenir), Association pour la Recherche contre le Cancer, and Fondation pour la Recherche Médicale.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Miard, S., Fajas, L. Atypical transcriptional regulators and cofactors of PPARγ. Int J Obes 29 (Suppl 1), S10–S12 (2005). https://doi.org/10.1038/sj.ijo.0802906
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0802906
Keywords
This article is cited by
-
Activating PIK3CA mutation promotes adipogenesis of adipose-derived stem cells in macrodactyly via up-regulation of E2F1
Cell Death & Disease (2020)
-
Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4/6 inhibitors
Breast Cancer Research and Treatment (2020)
-
Deletion of intestinal Hdac3 remodels the lipidome of enterocytes and protects mice from diet-induced obesity
Nature Communications (2019)
-
Characterization of the promoter region of the bovine long-chain acyl-CoA synthetase 1 gene: Roles of E2F1, Sp1, KLF15 and E2F4
Scientific Reports (2016)
-
Cubilin expression is monoallelic and epigenetically augmented via PPARs
BMC Genomics (2013)